Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction. Rare diseases (RH) are chronic, progressive and disabling or fatal. They affect very few people, their prevalence is very low: from 5 in 10,000 individuals in Europe, 7.5 in the USA. UU and 4 in Japan. It is estimated that there are around 5000 to 7000 ERs * and they affect 5 or 6% of the population. Many of them are genetic syndromes, for example inherited metabolic diseases.
Boy R, Schwartz IVD, Krug BC, Santana- da-Silva LC, Steiner CE, Acosta A X., Ribeiro, E. M.; Galera, M. F.; Leivas, P. G. C., Braz, M. Ethical issues related to the Access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I. JME. 2011;037150: 1-7.
Daniels N. Justice and Justification. Reflective equilibrium in theory and practice, Cambridge University Press. 1996.
Denis A, Megaert L, Fostier C, Cleemput I, Simoens S. A comparative study of European rare disease and orphan drug markets. Health Policy. 2004; 97: 173-179.
Eurordis. The voice of 12.000 patients. Experiences and expecations of rare diseases patients on diagnosis and care in Europe. 2010.
Disponible en: http://www.eurordis.org/IMG/pdf/voice_12000_patients/EURORDISCARE_FULLBOOKr.pdf
Hawkes N, Cohen, D. What makes an Orphan Drug? BMJ. 2010; 341: 1076-1079.
Huyard C. How did uncommon disorders become ‘rare diseases’? History of a boundary object, Sociology of Heatlth & Illness. 2009; 31, 4: 463-477.
Largent E, Pearson S. Which Orphans Will Find a Home? The Rule of Rescue in Resource Allocation for Rare Diseases. Hastings Center Report. 2012; 42, Issue 1, pp.: 27-34.
Lazor R, D Amato Sizonenko, L. Maladies rares et médicaments orphelins: un enjeu de santé publique? Bulletin des médecins suisses. 2011; 92: 28-29; 1083-1086.
Luna F. Elucidating the Concept of Vulnerability. Layers not Labels. IJFAB 2009; 2:1.
Nicholl D. Open letter to prime minister David Cameron and health secretary Andrew Lansley? BMJ. 2010; 341:1080.
Star S. L, Griesemer J. Institutional ecology, “translation” and boundary objects: amateurs and professionals in Berkeley´s museum of Vertebrate Zoology, Social Studies of Science. 1989; 19: 387- 420.
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.